WE LOOK FORWARD TO WELCOMING THE LIFE SCIENCES COMMUNITY TO MUNICH! Just some of the Life Sciences organisations who attended last year:
  • Syngenta
  • AstraZeneca
  • Kymab
  • Bayer Intellectual Property
  • Merck Sharp & Dohme
  • Eli Lilly
  • Gilead
  • Tigenix
  • Monsanto
  • Lundbeck
  • Novartis
  • NBE Therapeutics
  • Gilead
  • Sotio
  • F-Star
  • Teva
Testimonials

“The IP Life Science Summit 2016 was a rewarding experience due to the competent and experienced faculty addressing current complex issues that are of interest to those who are involved with intellectual Property.”Past attendee

“The hottest topics were covered by high level speakers and the networking opportunities were great”Nicolas Ruiz, Esteve

“Very interesting, size of group was excellent”Dr Margrit Hillmann, Bayer HealthCare

“Excellent content, interesting subjects” – Simon Bradbury, Appleyard Lees

“Very interactive and great examples of case law” – Sakura Holloway, Benitec Biopharma

“I really enjoyed the conference, it had a good choice of presentations” – Lindsey Kent, Eli Lilly

“Very well organized, all speakers of high quality”Past attendee

Come and join our expert speakers and attendees from around the world and benefit from two days of unrivalled insight with lively, interactive discussion and ample networking opportunities

A MUST-ATTEND EVENT FOR:

  • In-House General Counsel
  • Head of IP
  • Directors of IP, Patents and Legal Affairs
  • VP/SCP of Patents
  • IP Counsel
  • IP Managers
  • Patent Managers
  • Head of R&D
Private Practice Lawyers and Patent Attorneys specialising in:
  • Intellectual Property and Patent
  • Life Sciences
  • European Patent
Please contact us if you need any further information:
For sponsorship opportunities: Sofiane Guerni Tel: +44 (0)20 7878 6870 [email protected]
For questions about this year’s program/content Melanie Boulton Tel: +44 (0) 20 7878 6961 [email protected]
For Marketing support and media partnership opportunities: Sara H. Luna Tel: +44 (0)20 7878 6995 [email protected]